Expand INKT Menu
INKT MENU

INKT Stock Posts


INKT #MinkTherapeutics stock declines -15.4% in premarket,

Premarket Decliner

INKT Mink Therapeutics17.50+3.30+23.2%

Premarket:14.80-2.70 (-15.4%)

MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results

Globe NewswireThu, 14-Aug 7:30 AM

Market Data Delayed 15 Minutes